Clinical Trial Update: AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of AZD1775 in combination with carboplatin and paclitaxel for squamous cell carcinoma of the lung has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• Adavosertib (adavosertib)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-01-10